Alcoholic liver disease is frequently accompanied by portal hypertension. We have previously shown that alcohol intake in awake, unrestrained rats is followed by an increase in portal tributary blood flow. In this study, the effect of ethanol on splanchnic hemodynamics in rats with portal hypertensi
Effects of propylthiouracil and methimazole on splanchnic hemodynamics in awake and unrestrained rats
β Scribed by Tsunehisa Kawasaki; Frederick J. Carmichael; Gwynne Giles; Victor Saldivia; Yedy Israel; Hector Orrego
- Publisher
- John Wiley and Sons
- Year
- 1989
- Tongue
- English
- Weight
- 672 KB
- Volume
- 10
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
β¦ Synopsis
The treatment of alcoholic liver disease with propylthiouracil is based on its effect of suppressing the ethanol-induced increase in hepatic oxygen consumption. It has been postulated that liver necrosis ensues when the increase in oxygen demand by the liver exceeds oxygen delivery to this organ. Data are now presented which show that propylthiouracil also increases portal blood flow in awake, unrestrained rats.
Liver blood flow was determined using the labeled microsphere technique in rats at various intervals (0.25, 0.5, 1.0, 3.0,6.0 and 24 hr) after oral propylthiouracil (50 mg per kg). Administration of propylthiouracil (dose range: 6.25 to 100.0 mg per kg) produced a dose-dependent increase in portal blood flow when given either orally or intraarterially. Maximal flows were obtained with 50 mg per kg (controls = 37.8 f 1.5, oral propylthiouracil = 50.7 +I 2.2 ml. kg-lernin-'). This increase in portal blood flow was accompanied by a decrease in preportal vascular resistance (controls = 2.61 * 0.16; propylthiouracil, 50 mg per kg = 1.79 f 0.09 mmHg per ml. kg-" min-'). These effects were correlated with the plasma concentrations of propylthiouracil (r = 0.67, n = 68, p I 0.001). The effect of oral propylthiouracil(50 mg per kg) on portal blood flow started at 0.5 hr and lasted for 6 hr after administration, whereas total liver blood flow was increased for 3 hr. Oral propylthiouracil (50 mg per kg) for 5 days resulted in a 53% increase in thyroid weight, an 85% reduction in ' "I thyroid uptake and a 74% decrease in serum thyroxine concentration. This treatment, however, did not modify portal blood flow, nor the response to acute propylthiouracil. Oral administration of equipotent doses of another antithyroid drug, methimazole (10 and 20 mg per kg), had no effect on portal blood flow. Because of the rapid increase in portal blood flow following a single oral or parenteral dose of propylthiouracil and the lack of effect of methimazole, it is concluded that this response of propylthiouracil is independent of its effect on the thyroid gland and of intestinal absorption. The increase in portal blood flow can contribute to the protective effect of
π SIMILAR VOLUMES
Portal hypertension is associated with splanchnic hyperemia and increased plasma levels of prostacyclin. Recently, nitric oxide was proposed as a mediator of this arterial vasodilatation. We hypothesized that portal hypertension alters the relative contribution of prostacyclin and nitric oxide to sp
Serotonergic mechanisms have recently been implicated in the pathogenesis of portal hypertension; this suggests that blockade of serotonin S2 receptors may be a new approach for the pharmacological therapy of portal hypertension. This study was aimed at investigating the effects of ritanserin, a sel
Present investigations support major contributions from increases in both portal blood flow and portal vascular resistance in the mechanism that maintains portal hypertension. B-Adrenergic blockers have been shown to reduce the elevated portal blood flow component. The possibility that nitroglycerin